We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NEO market cap is 934.32M. The company's latest EPS is USD -0.6117 and P/E is -11.88.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 156.24M | 164.5M | 167.82M | 172M | 168.04M |
| Operating Income | -30.57M | -21.94M | -21.2M | -18.4M | -27.83M |
| Net Income | -27.06M | -18.64M | -17.7M | -15.32M | -25.92M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 444.45M | 484.33M | 509.73M | 591.64M | 660.57M |
| Operating Income | -13.99M | -118.75M | -157.62M | -107.74M | -92.11M |
| Net Income | 4.17M | -8.35M | -144.25M | -87.97M | -78.73M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.64B | 1.64B | 1.64B | 1.64B | 1.6B |
| Total Liabilities | 716.93M | 727.39M | 732.9M | 735.7M | 713.16M |
| Total Equity | 923.41M | 915.88M | 908.21M | 902.34M | 888.27M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 988.33M | 1.87B | 1.74B | 1.68B | 1.64B |
| Total Liabilities | 294.04M | 761.5M | 742.01M | 739.69M | 735.7M |
| Total Equity | 694.29M | 1.11B | 998.02M | 941.54M | 902.34M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.92M | -12.02M | -2.78M | 7.02M | -25.33M |
| Investing | 14.53M | 21.84M | 18.32M | 12.86M | 3.56M |
| Financing | 816k | 2.78M | 3.96M | 4.65M | 949k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.46M | -26.72M | -65.99M | -1.95M | 7.02M |
| Investing | -159.44M | -632.37M | 517k | 76.71M | 12.86M |
| Financing | 235.6M | 725.29M | 11.83M | 4.55M | 4.65M |
| Market Cap | 934.32M |
| Price to Earnings Ratio | -11.88 |
| Price to Sales Ratio | 1.42 |
| Price to Cash Ratio | 2.55 |
| Price to Book Ratio | 1.04 |
| Dividend Yield | - |
| Shares Outstanding | 128.69M |
| Average Volume (1 week) | 1.66M |
| Average Volume (1 Month) | 2.06M |
| 52 Week Change | -48.18% |
| 52 Week High | 19.115 |
| 52 Week Low | 6.08 |
| Spread (Intraday) | 0.28 (3.71%) |
| Company Name | NeoGenomics Inc |
| Address |
112 north curry street carson city, nevada 89703 |
| Website | https://www.neogenomics.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
